Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center Where you're treated first, matters. To make an appointment, call (844)-422-9799
(4311)

Connect with us:
www.mskcc.org
https://twitter.com/MSKCancerCenter
www.instagram.com/memorialsloankettering
youtube.com/user/mskcc

Our main campus and inpatient hospital are located on the Upper East Side of Manhattan. We also have outpatient facilities in Commack, Uniondale, and Hauppauge on Long Island, New York; West Harrison in Westchester County, New York; and Basking Ridge, Montvale, and Middletown in New Jersey; as well as several locations in New York City.

Employee Spotlight | “Every department I’ve been a part of at MSK over the past 14 years has been very mission-based and...
02/25/2026

Employee Spotlight | “Every department I’ve been a part of at MSK over the past 14 years has been very mission-based and focused on finding solutions," says Terron Browne, a Project Manager for the Design & Construction team at MSK. "I really value that."

When Terron Browne joined MSK in 2012, it wasn’t a title or a role that stood out to him first — it was the people. From the start, he noticed something that felt genuine: colleagues who truly cared about the work and about one another.

Over the years, his path has taken him across the organization, from ambulatory operations to digital health and now Design & Construction, even participating in Cycle for Survival. Each move reflects MSK’s culture of opportunity, but also Terron’s willingness to keep learning, growing, and saying yes to new challenges.

Today, as a Project Manager in Design & Construction, Terron focuses on implementation, helping ensure major projects move forward smoothly. Despite the different teams and roles, Terron sees a common thread running through his career. “At the core, it’s always been about serving our patients," he shares. "That’s the through line, and that’s why I’m still here.”

When reflecting on Black History Month, Terron emphasizes awareness and intention. “We have a diverse workforce, and people are impacted differently by environmental, cultural, and political forces," he shares. "Being open to differences in perspective goes a long way in creating a healthy, supportive environment.”

Right now, researchers at MSK are leading investigations into the causes of early-onset cancer — examining everything fr...
02/24/2026

Right now, researchers at MSK are leading investigations into the causes of early-onset cancer — examining everything from genetics to environmental factors to lifestyle and biology.

"For breast cancer specifically, We’re studying how earlier menstruation and delayed later childbearing may be extending exposure to reproductive hormones, potentially increasing risk," says Dr. Shari Goldfarb, an MSK breast medical oncologist. "Philanthropy plays a vital role in making research like this possible."

This month, consider supporting MSK's work towards discovering therapies to bring hope to people impacted by cancer. Today, your gift goes 2X further to fund cancer care and research that saves lives, not only today but for years to come. Learn more: https://bit.ly/3OyNpG7

02/23/2026

After the major snowstorm that struck our area, all MSK sites plan to open at their normal time on Tuesday, February 24.

If we need to reschedule or change your visit to a video visit, we will call you. If you want to reschedule, call your care team.

Check back here for updates.

02/22/2026

Winter storm update: Due to severe weather, MSK Westchester is closed today, Monday, February 23. Patients will be contacted about rescheduling their appointments.

For patients with appointments at other MSK sites: If we need to reschedule or change your visit to a video visit, we will call you. If you want to reschedule, call your care team.

"I was diagnosed with stage 3 re**al cancer at 28 — just months after the birth of my son. The news was devastating."Kel...
02/19/2026

"I was diagnosed with stage 3 re**al cancer at 28 — just months after the birth of my son. The news was devastating."

Kelly, an MSK patient, feared her dream of a big family was shattered.

She enrolled in a clinical trial co-led by Dr. Andrea Cercek, Co-Director for the Center for Young Onset Colore**al and Gastrointestinal Cancer at MSK, and Dr. Luis Diaz Jr., an MSK gastrointestinal medical oncologist, investigating whether people whose re**al tumors have a specific genetic mutation could be treated with immunotherapy alone

She received infusions of a form of immunotherapy called a checkpoint inhibitor, which helps the immune system recognize and attack cancer cells.

And after the ninth treatment, the seemingly impossible happened. Every single person in the trial saw their tumor vanish. Including Kelly. It happened without chemotherapy, radiation, or surgery — and ultimately preserved her fertility.

Months after stopping treatment, Kelly learned she was pregnant with her second child, and today, is a mom of three.

This month, help support Memorial Sloan Kettering Cancer Center (MSK)'s work towards discover therapies to help patients like Kelly and bring hope to people impacted by cancer. Today, your gift goes 2X further to fund cancer care and research that saves lives, not only today but for years to come. Learn more: https://bit.ly/4aFSWlq

This week, tutus, twirls, and big smiles filled MSK Kids as we welcomed ballerina Sara Adams from the New York City Ball...
02/19/2026

This week, tutus, twirls, and big smiles filled MSK Kids as we welcomed ballerina Sara Adams from the New York City Ballet for a very special visit! 🩰✨

Maureen once wondered if she would ever feel like herself again. After her light chain (AL) amyloidosis returned followi...
02/18/2026

Maureen once wondered if she would ever feel like herself again. After her light chain (AL) amyloidosis returned following a second stem cell transplant, everyday tasks – even walking – became more difficult.

In July 2024, Maureen joined a CAR T cell therapy clinical trial at MSK, led by Dr. Heather Landau. Just days later, she noticed a change. Maureen remembers telling her husband, “I know this sounds crazy, but I’m walking in the hall, I don’t have chest tightness, and my legs are picking up like the good old days.”

Ten days after leaving the hospital, Maureen walked four miles with her family. Soon after, she climbed 137 steps to the top of Montauk Point Lighthouse. Today, she is hiking, biking, and traveling again with the people she loves.

Learn from physician scientist Dr. Karlo Perica how this immunotherapy is changing what is possible for patients like Maureen: https://bit.ly/3OnfCQ3

02/17/2026

Love was in the air...and at the MSK Caring Canines Kissing Booth. ❤️

Bear, Mancha, Marcello, Nellie, Oliver, and Oscar proudly represented our MSK Caring Canines to spread Valentine's Day love and comfort to MSK patients and staff. DYK our dedicated teams of therapy dogs visit more than 9,000 patients every year?

02/17/2026

For more than 20 years, Maureen lived with light chain (AL) amyloidosis, a rare and relentless blood disease. Then she enrolled in a CAR T cell clinical trial made possible by years of research at Memorial Sloan Kettering Cancer Center (MSK).

The trial was led by MSK bone marrow transplant specialist Dr. Heather Landau. It uses a patient’s own immune cells that have been re-engineered to fight disease – the focus of research by physician scientist Dr. Karlo Perica, who is building on MSK's pioneering work in CAR T therapy more than a decade ago.

Just one week after her CAR T-cell infusion, Maureen’s blood tests were all normal, and she felt great.

Watch more Saved by Science stories on our YouTube 🧬

“I was basically told that I had a rare and aggressive cancer three weeks before we were going to go on the road.” For y...
02/13/2026

“I was basically told that I had a rare and aggressive cancer three weeks before we were going to go on the road.”

For years, Mary-Kate, 34, and her husband, Scott, had been planning to pursue a life on the road living in a van. In March 2024, during a series of health check-ups ahead of this new adventure, Mary-Kate's doctor recommended that she get a mammogram due to her family history of breast cancer.

The mammogram came back showing a cluster of concerning calcifications, and a biopsy confirmed she had triple negative breast cancer. “If we hadn’t planned to begin full-time van life, I would have never made that appointment,” says Mary-Kate.

Mary-Kate and Scott postponed their plans and she began treatment at MSK Monmouth with MSK breast surgeon Dr. Laurie Kirstein, breast oncologist Dr. Adam Widman, and radiation oncologist Dr. Beryl McCormick. Her treatment plan included a lumpectomy, three months of chemotherapy with scalp cooling, and 20 rounds of radiation.

In September 2024, she rang the end-of-treatment bell and was declared NED (no evidence of disease) in October 2024.

Today, Mary-Kate, Scott, and their dog, Floyd, are now happily on the road, prioritizing the healing benefits of being in nature. “My body feels strong again. The visual remnants of what chemotherapy did to my body have slowly evaporated,” Mary-Kate says. “Fear has loosened its grip on me, and my confidence is slowly returning. I’ve reclaimed my life, and it feels richer than ever before.”

Her advice for other young adults diagnosed with cancer: Sometimes age can act as a discriminating factor when it comes to health, but push to get seen; to get screenings; to advocate for yourself.

“When you’re first diagnosed with cancer, you just stop and think, ‘OK, how many years do I have left, and what do I nee...
02/11/2026

“When you’re first diagnosed with cancer, you just stop and think, ‘OK, how many years do I have left, and what do I need to get done in those years?’” says Ellen, an MSK ovarian cancer patient. “I never thought my life would be extended like this. Now it’s exciting to think, maybe I’ll get to meet my grandkids.”

By participating in an MSK clinical trial, led by gynecological oncologist Dr. Rachel Grisham and based on a lab discovery by physician-scientist Dr. David Solit, Ellen got early access to a drug targeting the mutation driving her rare cancer.

The results were dramatic: within four months, Ellen’s cancer had shrunk by 70%.

Read more about this FDA-approved treatment and the years of research that made it possible: https://www.mskcc.org/news/new-drug-treatment-for-low-grade-serous-ovarian-cancer-lgsoc-sparked-by-decade-old-discovery?utm_source=Facebook&utm_medium=Organic+Social+&utm_term=&utm_content=Images+of+Ellen&utm_campaign=Saved+by+Science

02/10/2026

In 2014, Dr. David Solit, a physician-scientist at Memorial Sloan Kettering Cancer Center (MSK), set out to decode the mutations that drive a rare type of ovarian cancer. Nearly 10 years later, that laboratory work became Ellen’s lifeline.

Facing a hard to treat diagnosis that resisted standard care, Ellen joined a clinical trial led by MSK gynecological oncologist Dr. Rachel Grisham -- based on Dr. Solit’s discovery a decade ago.

The results were dramatic. Within four months of taking a drug targeting the mutation, Ellen’s cancer had shrunk by 70%.

Watch more Saved by Science stories on YouTube: https://bit.ly/3ZLODjv

Address

New York, NY

Alerts

Be the first to know and let us send you an email when Memorial Sloan Kettering Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Memorial Sloan Kettering Cancer Center:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category